In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price...
ترست بايلوت
منذ 4 أيام
منذ أسبوع
منذ 3 أيام
منذ 5 أيام